CatalystPit

ATHEALTERITY THERAPEUTICS LTD

NASDAQ · Pharmaceutical Preparations
Last close $3.65 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-08 · Marks Peter Ashley (Director) · BUY
  • 2026-09-08 · Stamler David Allen (Chief Executive Officer) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders23
Shares held394,548
Value$2.02M
Percent of shares outstanding0.18%
As of quarter end2026-06-30
RECENT NEWS
  • Alterity Therapeutics to Present at the Canaccord Genuity Drug and Device Conference
  • Alterity Therapeutics' ATH434 slows MSA decline 52% versus placebo at week 52
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
ALTERITY THERAPEUTICS LTD (ATHE) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit